ASCO 2019 – presentations and articles

During 2019 ASCO General Meeting (American Society of Clinical Oncology), Oncopeptides presented new data from phase 1/2 O-12-M1 trial evaluating melflufen in RRMM. These data was presented by Professor Paul G. Richardson, see poster as well as publications in the media, several external links to videos and Twitter, regarding publications in the media.